MiR-574-3p inhibits glucose toxicity-induced pancreatic β-cell dysfunction by suppressing PRMT1.

MLA

Lv, Lixia, et al. “MiR-574-3p Inhibits Glucose Toxicity-Induced Pancreatic β-Cell Dysfunction by Suppressing PRMT1.” Diabetology & Metabolic Syndrome, vol. 14, no. 1, July 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13098-022-00869-y.

APA

Lv, L., Wang, X., Shen, J., Cao, Y., & Zhang, Q. (2022). MiR-574-3p inhibits glucose toxicity-induced pancreatic β-cell dysfunction by suppressing PRMT1. Diabetology & Metabolic Syndrome, 14(1), 1–11. https://doi.org/10.1186/s13098-022-00869-y

Chicago

Lv, Lixia, Xiumin Wang, Jinhua Shen, Ying Cao, and Qin Zhang. 2022. “MiR-574-3p Inhibits Glucose Toxicity-Induced Pancreatic β-Cell Dysfunction by Suppressing PRMT1.” Diabetology & Metabolic Syndrome 14 (1): 1–11. doi:10.1186/s13098-022-00869-y.